ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")…
NY Artisinal Initiates Coverage of LuxUrban Hotels, Launches Independent Investigation into Financial Disclosures and Legal Filings
Los Angeles, CA, Oct. 10, 2025 (GLOBE NEWSWIRE) -- NY Artisinal, a New…
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy
LA PALMA, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc.…
Morpheus Super Premium Whisky: Radico Khaitan Ltd. Expands the portfolio, initiates launch in Uttar Pradesh
NEW DELHI, July 1, 2025 /PRNewswire/ -- Radico Khaitan Ltd., one of the…
Quantum Metal Recovery Inc. Responds to Besra Gold’s ASX Announcement, Initiates Legal Proceedings in Ontario
PENANG, Malaysia, June 6, 2025 /PRNewswire/ -- Quantum Metal Recovery Inc. (QMRI),…
AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology
Third asset to advance into clinical trials, validating broad potential of Launch-iT…
